CD4+ TILs can recruit dendritic cells that can prime T cells to exert their cytotoxic effects by secreting perforin, granzyme B, or Fas ligand (cell death receptor ligand; FasL; CD95L), which may directly kill cancer cells. The gene discussed is FASLG; the disease is cancer.